Related Experiment Video
Updated: Aug 17, 2026

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
C-reactive protein, atherosclerosis and kidney function in hypertensive patients
M J Hommels1, A J A M van der Ven, A A Kroon
1Department of Medicine, University Hospital Maastricht, The Netherlands.
Insights
High-sensitivity C-reactive protein (hsCRP) levels are higher in patients with atherosclerosis in the aorta and renal arteries. This suggests a link between inflammation and vascular disease, though renal function also plays a role.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Inflammation Biology
Background:
- Previous research links C-reactive protein (CRP) to coronary and carotid atherosclerosis.
- High-sensitivity CRP (hsCRP) is a marker of systemic inflammation.
- Atherosclerosis affects major arteries, including those supplying the kidneys.
Purpose of the Study:
- To investigate the association between hsCRP levels and atherosclerotic lesions in the renal arteries and abdominal aorta.
- To determine if hsCRP is a marker for atherosclerotic renovascular disease.
- To explore potential confounding factors in the hsCRP-atherosclerosis relationship.
Main Methods:
- Prospective study involving 95 hypertensive patients undergoing digital subtraction angiography (DSA) for suspected renovascular disease.
- Blood samples collected during DSA for hsCRP measurement.
- Assessment of atherosclerotic lesions in renal arteries and abdominal aorta; renal artery stenosis defined as ≥50%.
Main Results:
- Median hsCRP concentrations were significantly higher in patients with aortic/renal artery atherosclerosis (4.6 mg/l) compared to those without (1.7 mg/l; P < 0.005).
- hsCRP levels were elevated in patients with >50% renal artery stenosis.
- Associations were confounded by serum creatinine, creatinine clearance, age, and gender; an inverse relationship between creatinine clearance and hsCRP was observed (P < 0.05).
Conclusions:
- hsCRP concentrations are associated with atherosclerotic lesions in the renal arteries and abdominal aorta.
- Atherosclerotic renal artery stenosis may be part of a systemic inflammatory vascular disease.
- Elevated hsCRP may also be linked to impaired renal function.
Abstract:
Previous studies have shown a relationship between coronary or carotid atherosclerosis and C-reactive protein (CRP) concentrations. In the present investigation, we evaluated the relationship between high-sensitivity CRP (hsCRP) concentrations and the presence of atherosclerotic lesions in the renal arteries and/or abdominal aorta. In 95 hypertensive patients who underwent intra-arterial DSA on suspicion of renovascular disease, blood was sampled during the procedure for measurement of hsCRP. The presence of atherosclerotic lesions was assessed at the level of the renal arteries and the abdominal aorta. Haemodynamically significant renal artery stenosis was diagnosed when 50% or more stenosis was observed. Patients with fibromuscular disease (n = 8) or incomplete data (n = 4) were excluded from analysis. The results revealed that the median hsCRP concentrations were significantly higher among the 57 patients with atherosclerosis of the aorta and/or renal arteries compared to those in the 26 patients without any angiographic lesions (4.6 vs 1.7 mg/l; P < 0.005). Moreover, in patients with renal artery stenosis, levels of hsCRP were higher when the degree of stenosis exceeded 50%. However, the association between hsCRP and the presence of atherosclerosis appeared to be confounded by serum creatinine, creatinine clearance, age and gender. In the whole group a significant inverse relationship was found between creatinine clearance and hsCRP (P < 0.05). In conclusion, hsCRP concentrations are related to atherosclerotic lesions in the renal arteries and the abdominal aorta. While this supports the view that atherosclerotic renal artery stenosis is part of a systemic inflammatory vascular disease, increased concentrations of CRP may also coincide with decreased renal function.
Related Concept Videos
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension and Regulation of Blood Pressure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...